5 Results for "

aberrant mitosis

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "aberrant mitosis" in MCE Product Catalog:

Cat. No.: HY-111425
CAS No.: 1370046-40-4
Purity:  99.88%
연구분야:  

Cancer

SSE15206 is a microtubule polymerization inhibitor (GI50 = 197 nM in HCT116 cells) that overcomes multidrug resistance. Causes aberrant mitosis resulting in G2/M arrest due to incomplete spindle formation in cancer cells .
loading...
    loading...
Cat. No.: HY-P10812
CAS No.: 1631984-43-4
Target:  

NADH Dehydrogenase

연구분야:  

Cancer

CP61 is a CtBP1 and CtBP2 inhibitor that binds to dimeric CtBP1 and allosterically inhibits NADH binding, disrupting the NADH-dependent dimerization of CtBP1 and CtBP2, inducing aberrant mitosis and micronucleus formation, thereby inhibiting cell proliferation and colony formation. CP61 can be used in breast cancer research .
loading...
    loading...
Cat. No.: HY-P10812A
Target:  

NADH Dehydrogenase

연구분야:  

Cancer

CP61 acetate is a CtBP1 and CtBP2 inhibitor that binds to dimeric CtBP1 and allosterically inhibits NADH binding, disrupting the NADH-dependent dimerization of CtBP1 and CtBP2, inducing aberrant mitosis and micronucleus formation, thereby inhibiting cell proliferation and colony formation. CP61 acetate can be used in breast cancer research .
loading...
    loading...
Cat. No.: HY-111425R
CAS No.: 1370046-40-4
SSE15206 (Standard) is the analytical standard of SSE15206 (HY-111425). This product is intended for research and analytical applications. SSE15206 is a microtubule polymerization inhibitor (GI50 = 197 nM in HCT116 cells) that overcomes multidrug resistance. Causes aberrant mitosis resulting in G2/M arrest due to incomplete spindle formation in cancer cells .
loading...
    loading...
Cat. No.: HY-118447
CAS No.: 443913-79-9
Target:  

CDK Survivin

연구분야:  

Cancer

RO0505124 is a selective CDK4 inhibitor with an IC50 of 20 nM. RO0505124 reversibly binds the ATP pocket of the kinase. RO0505124 induces G1 phase arrest in cancer cells via reduced retinoblastoma protein (Rb) phosphorylation, blocking S phase progression. RO0505124 exhibits anti-proliferative activity against various cancer cells. RO0505124 delays mitosis, induces aberrant mitosis with lagging chromosomes, driving mitotic slippage and formation of multinucleated or micronucleated cells. RO0505124 inhibits G2/M phase accumulation of survivin and borealin. RO0505124 can be used for the research of cancer .
loading...
    loading...